A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
Open accessAbstract
Familial Danish dementia (FDD), also known as heredopathia ophthalmo-oto-encephalica, is an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia. Neuropathological findings include severe widespread cerebral amyloid angiopathy, hippocampal plaques, and neurofibrillary tangles, similar to Alzheimer's disease. N-terminal sequence analysis of isolated leptomeningeal amyloid fibrils revealed homology to ABri, the peptide originated by a point mutation at the stop codon of gene BRI in familial British dementia. Molecular genetic analysis of the BRI gene in the Danish kindred showed a different defect, namely the presence of a 10-nt duplication (795–796insTTTAATTTGT) between codons 265 and 266, one codon before the normal stop codon 267. The decamer duplication mutation produces a frame-shift in the BRI sequence generating a larger-than-normal precursor protein, of which the amyloid subunit (designated ADan) comprises the last 34 C-terminal amino acids. This de novo- created amyloidogenic peptide, associated with a genetic defect in the Danish kindred, stresses the importance of amyloid formation as a causative factor in neurodegeneration and dementia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Disease-causing mutations in ITM2b result in C-terminally extended 277 aa mutant BRI2 proteins that are cleaved at the normal furin processing site to generate distinct 34 aa peptides (ABri in FBD and ADan in FDD) that accumulate in the brains of affected patients.
“Disease-causing mutations result in the production of C-terminally extended 277 aa mutant BRI2 proteins, which are cleaved at the normal furin processing site to generate distinct 34 aa peptides (ABri in FBD and ADan in FDD) that accumulate in the brains of affected patients (Vidal et al., 1999(Vidal et al., , 2000)).”
From BRI2 (ITM2b) Inhibits A Deposition In Vivo (2008) · cites this paper as Vidal et al., 2000
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Handbook of clinical neuropsychology
Filskov, S. B., & Boll, T. J. (1981) · Wiley eBooks · Cited by 777 · see citing works
Handbook of Clinical Neurology
Dinapoli, R. P. (1972) · Neurology · doi:10.1212/wnl.22.4.394 · Cited by 581 · see citing works
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466 · see citing works
Self-citationProteolytic Processing in the Secretory Pathway
Zhou, A., Webb, G. C., Zhu, X., & Steiner, D. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20745 · Cited by 457 · see citing works
Crook, R., Verkkoniemi, A., Pérez‐Tur, J., Mehta, N. D., Baker, M. C., Houlden, H., Farrer, M. J., Hutton, M., Lincoln, S., Hardy, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-452 · Cited by 347 · see citing works
Ghetti, B. F., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C. E., Frangione, B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.744 · Cited by 281 · see citing works
Self-citationExploring the Etiology of Alzheimer Disease Using Molecular Genetics
Lendon, C. L. (1997) · JAMA · doi:10.1001/jama.1997.03540340059034 · Cited by 272 · see citing works
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154 · see citing works
Transthyretin amyloidosis: A new mutation associated with dementia
Petersen, R. B., Goren, H., Cohen, M. L., Richardson, S. L., Tresser, N. J., Lynn, A., Gali, M., Estes, M. L., & Gambetti, P. L. (1997) · Annals of Neurology · doi:10.1002/ana.410410305 · Cited by 141 · see citing works
FAMILIAL CEREBRAL AMYLOID ANGIOPATHY WITH NONNEURITIC AMYLOID PLAQUE FORMATION
Plant, G. T., Révész, T., Barnard, R. O., Harding, A. E., & Gautier-Smith, P. C. (1990) · Brain · doi:10.1093/brain/113.3.721 · Cited by 132 · see citing works
Self-citationThe Neuropathology of Dementia
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511526886 · Cited by 115 · see citing works
Vidal, R., Garzuly, F., Budka, H., Lalowski, M. M., Linke, R., Brittig, F., Frangione, B., & Wısnıewskı, T. (1996) · Europe PMC (PubMed Central) · Cited by 108 · see citing works
Self-citationIsolation of Markers for Chondro-osteogenic Differentiation Using cDNA Library Subtraction
Deleersnijder, W., Hong, G., Cortvrindt, R., Poirier, C., Tylżanowski, P., Pittois, K., Marck, E. V., & Merregaert, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19475 · Cited by 106 · see citing works
Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type
Ghiso, J. A., Haltia, M., Prelli, F. C., Novello, J. C., & Frangione, B. (1990) · Biochemical Journal · doi:10.1042/bj2720827 · Cited by 85 · see citing works
Self-citationNew order from neurological disorders
Price, D. L. (1999) · Nature · doi:10.1038/399a003 · Cited by 82 · see citing works
Pittois, K., Deleersnijder, W., & Merregaert, J. (1998) · Gene · doi:10.1016/s0378-1119(98)00354-0 · Cited by 56 · see citing works
Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy
Murakami, T., Uchino, M., & Ando, M. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03373.x · Cited by 29 · see citing works
The Neuropathology of Dementia
Xuereb, J. H. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.282a · Cited by 21 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [1]Strömgrem E, Dalby A, Dalby M, Ranheim B. Acta Neurol Scand. 1970;46,(Suppl. 43):97–98. doi: 10.1111/j.1600-0404.1970.tb02219.x. [DOI] [PubMed] [Google Scholar] · DOI
- [8]Vidal R, Garzuly F, Budka H, Lalowski M, Linke R, Brittig F, Frangione B, Wisniewski T. Am J Pathol. 1996;148:361–366. [PMC free article] [PubMed] [Google Scholar]
- [10]Lendon C, Ashall F, Goate A. J Am Med Assoc. 1997;277:825–831. [PubMed] [Google Scholar]
Cited by
Sorted by citations
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629 · see citing works
Pathology of Neurodegenerative Diseases
Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665 · see citing works
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133 · see citing works
Structure-based classification of tauopathies
Shi, Y., Zhang, W., Yang, Y., Murzin, A. G., Falcon, B., Kotecha, A., van Beers, M., Tarutani, A., Kametani, F., Garringer, H. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03911-7 · Cited by 878 · see citing works
Self-citationReadhead, B., Haure-Mirande, J.-V., Funk, C. C., Richards, M. A., Shannon, P., Haroutunian, V., Sano, M., Liang, W. S., Beckmann, N. D., Price, N. D., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.023 · Cited by 708 · see citing works
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611 · see citing works
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609 · see citing works
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 582 · see citing works
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 565 · see citing works
Kalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441 · see citing works
Intracerebral hemorrhage: an update on diagnosis and treatment
Hostettler, I. C., Seiffge, D. J., & Werring, D. J. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1623671 · Cited by 345 · see citing works
The pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 344 · see citing works
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
Révész, T., Holton, J. L., Lashley, T., Plant, G. T., Frangione, B., Rostagno, A. A., & Ghiso, J. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0501-8 · Cited by 293 · see citing works
Self-citationSpontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy
Winkler, D. T., Bondolfi, L., Herzig, M. C., Jann, L., Calhoun, M. E., Wiederhold, K., Tolnay, M., Staufenbiel, M., & Jucker, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01619.2001 · Cited by 287 · see citing works
A decade of modeling Alzheimer's disease in transgenic mice
MCGOWAN, E., ERIKSEN, J., & HUTTON, M. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.007 · Cited by 287 · see citing works
Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View
Révész, T., Ghiso, J. A., Lashley, T., Plant, G. T., Rostagno, A. A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 286 · see citing works
Self-citationTransmissibility of systemic amyloidosis by a prion-like mechanism
Lundmark, K., Westermark, G. T., Nyström, S. N., Murphy, C. L., Solomon, A., & Westermark, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092205999 · Cited by 278 · see citing works
Mulugeta, S., Nguyen, V., Russo, S. J., Madesh, M., & Beers, M. F. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0009oc · Cited by 255 · see citing works
Intrinsic disorder in proteins associated with neurodegenerative diseases
Vladimir, N. (2009) · Frontiers in bioscience · doi:10.2741/3594 · Cited by 234 · see citing works
Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G., Willbold, D., Funke, S. A., Schilling, S., & Demuth, H.-U. (2009) · Biochemistry · doi:10.1021/bi900818a · Cited by 228 · see citing works
Miravalle, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003154200 · Cited by 217 · see citing works
Amyloid Fibril Protein Nomenclature - 2002
Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S.-I., Masters, C. L., Merlini, G., Saraiva, M. J., & Sipe, J. D. (2002) · Amyloid · doi:10.3109/13506120209114823 · Cited by 215 · see citing works
Self-citationBRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer
Sánchez‐Pulido, L., Devos, D. P., & Valencia, A. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02134-5 · Cited by 214 · see citing works
The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
Säftig, P., & Lichtenthaler, S. F. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.003 · Cited by 209 · see citing works
Britschgi, M., Olin, C. E., Johns, H. T., Takeda-Uchimura, Y., LeMieux, M. C., Rufibach, K., Rajadas, J., Zhang, H., Tomooka, B., Robinson, W. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904866106 · Cited by 201 · see citing works
Self-citationSporadic and Familial Cerebral Amyloid Angiopathies
Révész, T., Holton, J. L., Lashley, T., Plant, G. T., Rostagno, A. A., Ghiso, J. A., & Frangione, B. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00449.x · Cited by 199 · see citing works
Self-citationSURFACTANT PROTEIN C BIOSYNTHESIS AND ITS EMERGING ROLE IN CONFORMATIONAL LUNG DISEASE
Beers, M. F., & Mulugeta, S. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.101937 · Cited by 199 · see citing works
Amyloidosis and Alzheimer’s disease
Ghiso, J. A., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 189 · see citing works
Self-citationAmyloidogenesis of Natively Unfolded Proteins
Uversky, V. N. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533312 · Cited by 187 · see citing works
SQSTM1/p62: a potential target for neurodegenerative disease
Ma, S., Attarwala, I. Y., & Xie, X.-Q. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00516 · Cited by 185 · see citing works
Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B., & Ghiso, J. A. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61486-9 · Cited by 180 · see citing works
Self-citationIntegrated Analysis of the Cerebrospinal Fluid Peptidome and Proteome
Zougman, A., Pilch, B., Podtelejnikov, A. V., Kiehntopf, M., Schnabel, C., Kumar, C., & Mann, M. (2007) · Journal of Proteome Research · doi:10.1021/pr070501k · Cited by 174 · see citing works
Alzheimer disease therapy: Can the amyloid cascade be halted?
Golde, T. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17527 · Cited by 164 · see citing works
Vidal, R., Ghetti, B. F., Takao, M., Brefel‐Courbon, C., Uro‐Coste, E., Glazier, B. S., Siani, V., Benson, M. D., Calvas, P., Miravalle, L., et al. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.363 · Cited by 161 · see citing works
Self-citationPathogenesis of cerebral amyloid angiopathy
Rensink, A. A. M., de Waal, R. M. W., Kremer, B. P. H., & Verbeek, M. M. (2003) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.001 · Cited by 159 · see citing works
Benson, M. D., Liepnieks, J. J., Yazaki, M., Yamashita, T., Asl, K. H., Guenther, B. D., & Kluve‐Beckerman, B. (2001) · Genomics · doi:10.1006/geno.2000.6499 · Cited by 157 · see citing works
Fukutake, T. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.11.008 · Cited by 159 · see citing works
Genetics of Frontotemporal Dementia
Olszewska, D. A., Lonergan, R. M., Fallon, E., & Lynch, T. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0707-9 · Cited by 156 · see citing works
Regulated Intramembrane Proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b
Martin, L., Fluhrer, R., Reiß, K., Kremmer, E., Säftig, P., & Haass, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706661200 · Cited by 155 · see citing works
Uversky, V. N. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.36 · Cited by 141 · see citing works
Tamayev, R., Matsuda, S., Arancio, O., & D'Adamio, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100195 · Cited by 142 · see citing works
Matsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141 · see citing works
Self-citationHolton, J. L., Lashley, T., Ghiso, J. A., Brændgaard, H., Vidal, R., Guérin, C. J., Gibb, G., Hanger, D. P., Rostagno, A. A., Anderton, B. H., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.254 · Cited by 133 · see citing works
Self-citationHolton, J. L., Ghiso, J. A., Lashley, T., Rostagno, A. A., Guérin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63993-4 · Cited by 131 · see citing works
Self-citationKhan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 125 · see citing works
Translation readthrough mitigation
Arribere, J. A., Cenik, E. S., Jain, N., Hess, G. T., Lee, C. H., Bassik, M. C., & Fire, A. Z. (2016) · Nature · doi:10.1038/nature18308 · Cited by 116 · see citing works
BRI2 Interacts with Amyloid Precursor Protein (APP) and Regulates Amyloid β (Aβ) Production
Fotinopoulou, A., Tsachaki, M., Vlavaki, M., Poulopoulos, A., Rostagno, A., Frangione, B., Ghiso, J., & Efthimiopoulos, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500231200 · Cited by 114 · see citing works
Self-citationBRI2 (ITM2b) Inhibits A Deposition In Vivo
Kim, J., Miller, V. M., Levites, Y., West, K. J., Zwizinski, C. W., Moore, B. D., Troendle, F. J., Bann, M., Verbeeck, C., Price, R. W., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0891-08.2008 · Cited by 113 · see citing works
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146 · see citing works
Familial British dementia with amyloid angiopathy
Mead, S., James-Galton, M., Révész, T., Doshi, R. B., Harwood, G., Pan, E., Ghiso, J. A., Frangione, B., & Plant, G. T. (2000) · Brain · doi:10.1093/brain/123.5.975 · Cited by 112 · see citing works
Self-citationClinical phenotypes of Cerebral Amyloid Angiopathy
Maia, L. F., Mackenzie, I. R., & Feldman, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.054 · Cited by 104 · see citing works
Walker, L. C., & LeVine, H. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:1-2:083 · Cited by 105 · see citing works
BRICHOS - a superfamily of multidomain proteins with diverse functions
Hedlund, J., Johansson, J., & Persson, B. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-180 · Cited by 99 · see citing works
Golde, T. E. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00104.x · Cited by 98 · see citing works
Matsuda, S., Giliberto, L., Matsuda, Y., McGowan, E. M., & D'adamio, L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2094-08.2008 · Cited by 95 · see citing works
AmyPro: a database of proteins with validated amyloidogenic regions
Váradi, M., Baets, G. D., Vranken, W., Tompa, P., & Pancsa, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx950 · Cited by 90 · see citing works
Stevens, P. A., Pettenazzo, A., Brasch, F. E., Mulugeta, S., Baritussio, A., Ochs, M., Morrison, L. D., Russo, S. J., & Beers, M. F. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000147567.02473.5a · Cited by 89 · see citing works
Alzheimer’s disease – the journey of a healthy brain into organ failure
Golde, T. E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00523-1 · Cited by 90 · see citing works
Del Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86 · see citing works
Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 95 · see citing works
Steiner, H., Révész, T., Neumann, M., Romig, H., Grim, M. G., Pesold, B., Kretzschmar, H. A., Hardy, J., Holton, J. L., Baumeister, R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007183200 · Cited by 86 · see citing works
Self-citation(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00006-0 · Cited by 84 · see citing works
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
Chen, G., Abelein, A., Nilsson, H. E., Leppert, A., Andrade‐Talavera, Y., Tambaro, S., Hemmingsson, L., Kurudenkandy, F. R., Landreh, M., Biverstål, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02056-4 · Cited by 84 · see citing works
Fanutza, T., Prete, D. D., Ford, M. J., Castillo, P. E., & D'adamio, L. (2015) · eLife · doi:10.7554/elife.09743 · Cited by 81 · see citing works
Murine models of Alzheimer's disease and their use in developing immunotherapies
Wısnıewskı, T., & Sigurdsson, E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.004 · Cited by 80 · see citing works
Tamayev, R., & D’Adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-19 · Cited by 81 · see citing works
Willander, H., Hermansson, E., Johansson, J., & Presto, J. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08209.x · Cited by 80 · see citing works
Systemic Amyloid Deposits in Familial British Dementia*
Ghiso, J., Holton, J., Miravalle, L., Calero, M., Lashley, T., Vidal, R., Houlden, H., Wood, N., Neubert, T., Rostagno, A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105956200 · Cited by 80 · see citing works
Self-citationThe BRICHOS Domain, Amyloid Fibril Formation, and Their Relationship
Knight, S. D., Presto, J., Linse, S. S., & Johansson, J. (2013) · Biochemistry · doi:10.1021/bi400908x · Cited by 77 · see citing works
Coomaraswamy, J., Kilger, E., Wölfing, H., Schäfer, C., Kaeser, S. A., Wegenast‐Braun, B. M., Hefendehl, J. K., Wolburg, H., Mazzella, M. J., Ghiso, J. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001056107 · Cited by 74 · see citing works
Self-citationNeurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors
Lecordier, S., Manrique‐Castano, D., Moghrabi, Y. E., & ElAli, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.727590 · Cited by 76 · see citing works
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
Rostagno, A. A., Holton, J. L., Lashley, T., Révész, T., & Ghiso, J. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0182-4 · Cited by 76 · see citing works
Self-citationYazaki, M., Liepnieks, J. J., Barats, M. S., Cohen, A. H., & Benson, M. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00047.x · Cited by 73 · see citing works
El‐Agnaf, O. M. A., Nagala, S., PATEL, B. P., & Austen, B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4743 · Cited by 73 · see citing works
Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 72 · see citing works
Structure of Tau filaments in Prion protein amyloidoses
Hallinan, G. I., Hoq, M. R., Ghosh, M., Vago, F. S., Fernández, A., Garringer, H. J., Vidal, R., Jiang, W., & Ghetti, B. F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02336-w · Cited by 72 · see citing works
Self-citationMatsuda, S., Matsuda, Y., Snapp, E. L., & D'adamio, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.005 · Cited by 68 · see citing works
Lowe, J. S., Mirra, S. S., Hyman, B. T., & Dickson, D. W. (2008) · CRC Press eBooks · doi:10.1201/b13319-15 · Cited by 68 · see citing works
Tomidokoro, Y., Lashley, T., Rostagno, A., Neubert, T. A., Bojsen-Møller, M., Braendgaard, H., Plant, G., Holton, J., Frangione, B., Révész, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504038200 · Cited by 68 · see citing works
Self-citationLawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67 · see citing works
Prete, D. D., Lombino, F. L., Liu, X., & D'adamio, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108576 · Cited by 62 · see citing works
Complement Activation in Chromosome 13 Dementias
Rostagno, A. A., Révész, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Brændgaard, H., Plant, G. T., Bojsen‐Møller, M., Holton, J. L., Frangione, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206448200 · Cited by 64 · see citing works
Self-citationMolecular Pathophysiology of Uric Acid Homeostasis
Estiverne, C., Mandal, A. K., & Mount, D. B. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.12.006 · Cited by 63 · see citing works
Tamayev, R., Matsuda, S., Fà, M., Arancio, O., & D'adamio, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011689107 · Cited by 61 · see citing works
Oskarsson, M. E., Hermansson, E., Wang, Y., Welsh, N., Presto, J., Johansson, J., & Westermark, G. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715951115 · Cited by 61 · see citing works
Vidal, R., Barbeito, A. G., Miravalle, L., & Ghetti, B. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00164.x · Cited by 60 · see citing works
Self-citationPoska, H., Haslbeck, M., Kurudenkandy, F. R., Hermansson, E., Chen, G., Kostallas, G., Abelein, A., Biverstål, H., Crux, S., Fisahn, A., et al. (2016) · Biochemical Journal · doi:10.1042/bcj20160277 · Cited by 58 · see citing works
Proteolytic Processing of Familial British Dementia-associated BRI Variants
Kim, S., Creemers, J. W. M., Chu, S., Thinakaran, G., & Sisodia, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108739200 · Cited by 58 · see citing works
Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia
Ghiso, J. A., & Frangione, B. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3110 · Cited by 58 · see citing works
Self-citationBiomarkers for diseases with TDP-43 pathology
Steinacker, P., Barschke, P., & Otto, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.003 · Cited by 57 · see citing works
Rostagno, A. A., Tomidokoro, Y., Lashley, T., Ng, D., Plant, G. T., Holton, J. L., Frangione, B., Révész, T., & Ghiso, J. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5092-5 · Cited by 57 · see citing works
Self-citationMatsuda, S., Matsuda, Y., & D'adamio, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006403 · Cited by 57 · see citing works
BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease
Campo, M. D., Hoozemans, J. J. M., Dekkers, L.-L., Rozemüller, A. J. M., Korth, C., Müller‐Schiffmann, A., Scheltens, P., Blankenstein, M. A., Jiménez, C. R., Veerhuis, R., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.007 · Cited by 54 · see citing works
Sequence, genomic structure and tissue expression of Human BRI 3 , a member of the BRI gene family
Vidal, R., Calero, M., Révész, T., Plant, G. T., Ghiso, J. A., & Frangione, B. (2001) · Gene · doi:10.1016/s0378-1119(01)00374-2 · Cited by 56 · see citing works
Self-citationAdvances in molecular genetics and pathology of cerebrovascular disorders
Kalaria, R. N. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01836-1 · Cited by 56 · see citing works
Tamayev, R., Giliberto, L., Li, W., d’Abramo, C., Arancio, O., Vidal, R., & D'adamio, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3917-10.2010 · Cited by 55 · see citing works
Self-citationAxonal transport of British and Danish amyloid peptides via secretory vesicles
Choi, S., Vidal, R., Frangione, B., & Levy, E. (2003) · The FASEB Journal · doi:10.1096/fj.03-0730fje · Cited by 55 · see citing works
Self-citationClinical considerations in early-onset cerebral amyloid angiopathy
Banerjee, G., Collinge, J., Fox, N. C., Lashley, T., Mead, S., Schott, J. M., Werring, D. J., & Ryan, N. S. (2023) · Brain · doi:10.1093/brain/awad193 · Cited by 54 · see citing works
Iowa Variant of Familial Alzheimer’s Disease
Tomidokoro, Y., Rostagno, A. A., Neubert, T. A., Lu, Y., Rebeck, G. W., Frangione, B., Greenberg, S. M., & Ghiso, J. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090636 · Cited by 53 · see citing works
Self-citationRenal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A-II gene
Yazaki, M., Liepnieks, J. J., Yamashita, T., Guenther, B. D., Skinner, M. M., & Benson, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00024.x · Cited by 52 · see citing works
- Authors
- Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., & Frangione, B.
- Affiliations
- Department of Pathology, New York University School of Medicine, New York 10016; Department of Neuropathology, Institute of Neurology, London, WC1N3BG United Kingdom; Departments of Ophthalmology, Neuropathology and Neurology, Århus University Hospital, Århus, DK8000 Denmark; and The National Hospital for Neurology and Neurosurgery, London, WC1N3BG United Kingdom
- Aarhus University (DK)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-04-18
- Volume
- 97
- Issue
- 9
- Pages
- 4920-4925
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18333
- OpenAlex
- W2137091415
- Cited by
- 300
- References
- 18
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 13 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 14 · 2015: 19 · 2014: 11 · 2013: 9 · 2012: 8
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (5r35ag010953-07)
- National Institute on Aging (R37AG005891, R01AG008721, AG-08721, AG10953, AG05891)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- familial Danish dementia, amyloid peptides, Adán, cerebral amyloid angiopathy, frameshift mutation, de novo mutations, neurodegeneration
- MeSH terms
- Amino Acid Sequence, Amyloid, Base Sequence, Dementia, Denmark, Female, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Pedigree, Temporal Lobe, Sequence Alignment, Sequence Homology, Amino Acid, 3' Untranslated Regions, Gene Duplication, White People, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
